ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
减肥药
1,289.82
+40.12
3.21%
涨家数:
5
跌家数:
2
平家数:
- -
市盈率:
- -
高:
1,301.32
开:
1,249.67
低:
1,249.67
收:
1,249.70
数据加载中...
总览
新闻
辉瑞4月21日成交额为7.05亿美元
市场透视
·
04-22
诺和诺德与京东健康开启战略合作,将共同打造肥胖症科普专区
新京报
·
04-22
歌礼制药-B早盘涨超21% 礼来公布口服降糖药取得积极结果
金融界
·
04-22
礼来4月21日成交额为27.35亿美元
市场透视
·
04-22
歌礼制药-B早盘涨超21% 礼来公布口服降糖药取得积极结果
新浪港股
·
04-22
港股异动 | 歌礼制药-B(01672)早盘涨超22% 礼来公布口服降糖药积极结果 ASC30具备更大商业化BD潜力
智通财经
·
04-22
安进4月21日成交额为4.94亿美元
市场透视
·
04-22
Altimmune, Inc.盘中异动 急速拉升5.16%报4.79美元
市场透视
·
04-21
硕迪生物盘中异动 早盘股价大涨5.51%报22.96美元
市场透视
·
04-21
百亿富豪的生长激素不灵了,355亿“东北药茅”神话破灭?
市场资讯
·
04-21
响应“国家喊你减肥”号召,诺和诺德与京东健康开启战略合作
广州日报
·
04-21
减肥药迈入“吃药时代”?礼来口服神药试验成功,股价飙涨创25年新高!
金十数据
·
04-21
减重版司美格鲁肽中国说明书更新,纳入心血管获益结果
美港电讯
·
04-21
海外市场 | 美股继续调整,礼来口服减肥药火爆
Ofweek维科网
·
04-21
数据:UDS、VENOM、ALT 等代币将于下周迎来大额解锁,其中 UDS 解锁价值约 1490 万美元
BitPush
·
04-20
诺和诺德、礼来“二王争霸”,国产GLP-1抢夺新适应症,恒瑞医药们不想只做减肥神药
时代财经
·
04-19
中银证券安进债券季报解读:利润骤降与份额微变
新浪基金∞工作室
·
04-19
RootData:ALT 将于一周后解锁价值约 675 万美元的代币
BitPush
·
04-19
辉瑞:已计入风险,买入具有卓越估值和收益的股票
美股研究社
·
04-18
【沃森生物:20价肺炎球菌多糖结合疫苗获临床试验批准】沃森生物公告,公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》,通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品,新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型,用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家,国内尚未有20价肺炎球菌多糖结合疫苗上市销售。
金融界
·
04-18
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4599/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"减肥药","latestPrice":1289.8245,"timestamp":1746215999999,"preClose":1249.7039,"halted":0,"volume":75845285,"delay":0,"changeRate":0.032104,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":40.120605,"latestTime":"05-02 16:00:00 EDT","open":1249.6709,"high":1301.315,"low":1249.6709,"amount":8375367350.76205,"amplitude":0.041325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.931939,"peRate":32.937129,"turnoverRate":0.00718,"increases":5,"decrements":2,"flats":0,"marketCap":1381836112544,"floatMarketCap":1292379014240},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1301.315,"amplitude":0.041325,"preClose":1249.7039,"low":1249.6709,"pbRate":"9.931939","latestPrice":1289.8245,"volume":75845285,"delay":0,"open":1249.6709,"prevYearClose":1305.0607,"prevWeekClose":1313.4298,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1313.4298,"twentyDayClose":1265.6132,"sixtyDayClose":1394.0055,"secType":"PLATE","market":"US","turnoverRate":0.00718,"peRate":32.937129,"marketCap":1381836112544,"floatMarketCap":1292379014240,"timestamp":1746215999999,"nameCN":"减肥药"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529667398","title":"辉瑞4月21日成交额为7.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529667398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529667398?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:18","pubTimestamp":1745288323,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日,辉瑞成交额为7.05亿美元,成交额较昨日减少41.56%,当日成交量为3202.10万股。辉瑞于2025年4月21日跌0.45%,报22.04美元,该股过去5个交易日涨0.59%,年初至今跌15.55%,过去60日跌15.26%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-21|7.05亿|-41.56%|3202.10万|#|2025-04-17|12.06亿|44.24%|5407.37万|#|2025-04-16|8.36亿|-28.41%|3764.12万|#|2025-04-15|11.68亿|-14.48%|5181.47万|#|2025-04-14|13.66亿|14.34%|6190.09万|辉瑞是全球最大的制药公司之一,年销售额接近500亿美元。辉瑞在全球销售这些产品,国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422101850a461d03e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422101850a461d03e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002224.SGD","LU1066051498.USD","LU0321505439.SGD","LU1057294990.SGD","LU0985481810.HKD","LU0058720904.USD","SG9999011175.SGD","LU0868494617.USD","PFE","SG9999001176.SGD","BK4592","BK4534","LU1894683264.USD","BK4568","LU0321505868.SGD","BK4588","IE0002270589.USD","BK4007","IE00B19Z3581.USD","SG9999002232.USD","LU0234572021.USD","BK4599","LU0225771236.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU0170899867.USD","LU1894683348.USD","IE000M9KFDE8.USD","LU1066053197.SGD","SG9999001176.USD","BK4581","BK4585","IE00BLSP4452.SGD","BK4533","LU0306807586.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU1023059063.AUD","LU1883839398.USD","LU0306806265.USD","IE00BLSP4239.USD","LU0122379950.USD","LU0456855351.SGD","SG9999003800.SGD","BK4550","SG9999013999.USD"],"gpt_icon":1},{"id":"2529539359","title":"诺和诺德与京东健康开启战略合作,将共同打造肥胖症科普专区","url":"https://stock-news.laohu8.com/highlight/detail?id=2529539359","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529539359?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:05","pubTimestamp":1745287505,"startTime":"0","endTime":"0","summary":"新京报讯(记者王卡拉)4月21日,京东健康与诺和诺德在北京签署战略合作协议,将携手打造肥胖症公众科普专区,助力糖尿病一站式诊疗,全面赋能慢病管理数字化转型升级。为了应对严重慢性疾病的挑战,我国将“糖尿病防治行动”列为《健康中国行动(2019-2030年)》15个专项行动之一,并持续推进《“体重管理年”活动实施方案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504223384063334.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384063334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1591","BK1142","BK1589","LU0456827905.SGD","BK4532","BK1247","BK4588","BK1571","IE00BKVL7J92.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4585","06618","86618","LU0051755006.USD","BK4599","LU0154236417.USD","BK1615","BK1583","NVO","BK1515","LU1093756325.SGD","BK4007"],"gpt_icon":1},{"id":"2529676163","title":"歌礼制药-B早盘涨超21% 礼来公布口服降糖药取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529676163","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529676163?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:55","pubTimestamp":1745286943,"startTime":"0","endTime":"0","summary":"歌礼制药-B早盘上涨21.46%,现报6港元,成交额2550.55万港元。4月14日,辉瑞因潜在肝损伤终止开发GLP-1小分子受体激动剂Danuglipron。4月17日,礼来宣布口服药Orforglipron的III期ACHIEVE-1研究取得积极顶线结果,在糖化血红蛋白管理、体重控制和安全性方面均与注射剂型相仿,即将申报上市。\n\n\r\n 责任编辑:栎树","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/04/22095549737765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1232071149.USD","SG9999001176.SGD","LU0256863902.USD","LU1917777945.USD","BK4534","LLY","SG9999001176.USD","LU2106854487.HKD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2552382058.USD","LU0096364046.USD","LU2237443549.SGD","SG9999014906.USD","SG9999014880.SGD","LU0109391861.USD","BK1161","LU1366192091.USD","LU2063271972.USD","LU0672654240.SGD","LU2237443622.USD","SGXZ57979304.SGD","SGXZ51526630.SGD","BK4599","SG9999014914.USD","LU0943347566.SGD","BK4585","LU1551013425.SGD","LU1868836757.USD","LU2491050071.SGD","IE0004445239.USD","LU0471298777.SGD","LU1868836914.USD","LU0238689110.USD","BK1191","01477","LU0289739699.SGD","BK1574","01672","SG9999015945.SGD","LU1989771016.USD","LU2089984988.USD","SG9999018865.SGD","LU2750360641.GBP","LU0466842654.USD","LU0079474960.USD","LU0417517546.SGD","LU1623119135.USD","LU1988902786.USD","SGXZ31699556.SGD"],"gpt_icon":0},{"id":"2529036089","title":"礼来4月21日成交额为27.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529036089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529036089?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:52","pubTimestamp":1745286728,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日,礼来成交额为27.35亿美元,成交额较昨日减少70.11%,当日成交量为332.66万股。礼来于2025年4月21日跌2.61%,报818.02美元,该股过去5个交易日涨11.69%,年初至今涨6.14%,过去60日涨6.89%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-21|27.35亿|-70.11%|332.66万|#|2025-04-17|91.53亿|275.58%|1085.34万|#|2025-04-16|24.37亿|30.87%|330.26万|#|2025-04-15|18.62亿|-28.31%|245.81万|#|2025-04-14|25.98亿|-0.95%|346.12万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422095209a461c856&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422095209a461c856&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0640476718.USD","LU1035775433.USD","LU2089984988.USD","LU2211815571.USD","LU0122379950.USD","LLY","LU2360106947.USD","SGXZ81514606.USD","LU2471134796.USD","LU0094547139.USD","LU1023059063.AUD","LU0006306889.USD","LU1804176565.USD","LU1057294990.SGD","LU1720051108.HKD","LU2361045086.USD","SG9999018865.SGD","IE00BK4W5L77.USD","BK4533","LU1989771016.USD","IE0009355771.USD","LU0238689110.USD","LU0198837287.USD","IE00BJLML261.HKD","LU2491050154.USD","SG9999017495.SGD","LU1720051017.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4599","LU0672654240.SGD","LU1868836914.USD","LU2237443895.HKD","LU0471298777.SGD","LU1267930730.SGD","IE00BJT1NW94.SGD","LU2023250504.SGD","LU2237443622.USD","IE0002141913.USD","LU2264538146.SGD","LU0320765059.SGD","LU2106854487.HKD","LU2324357040.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU0058720904.USD","LU2468319806.SGD","SG9999001176.USD","SG9999014906.USD","SGXZ99366536.SGD"],"gpt_icon":1},{"id":"2529367503","title":"歌礼制药-B早盘涨超21% 礼来公布口服降糖药取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529367503","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529367503?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:49","pubTimestamp":1745286540,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 歌礼制药-B(01672)早盘上涨21.46%,现报6港元,成交额2550.55万港元。\n 4月14日,辉瑞因潜在肝损伤终止开发GLP-1小分子受体激动剂Danuglipron。4月17日,礼来宣布口服药Orforglipron的III期ACHIEVE-1研究取得积极顶线结果,在糖化血红蛋白管理、体重控制和安全性方面均与注射剂型相仿,即将申报上市。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetyyfe1157611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BJT1NW94.SGD","LU0882574055.USD","LU1548497426.USD","LU2237443382.USD","LU1366192091.USD","LU1868837300.USD","LU1868836591.USD","IE00BK4W5M84.HKD","LU1814569148.SGD","LU1712237335.SGD","LU1035775433.USD","LU2237443465.HKD","BK1574","LU0385154629.USD","IE00BK4W5L77.USD","LU0058720904.USD","BK4588","LU0689472784.USD","LU0943347566.SGD","01672","BK4516","SG9999014914.USD","BK4533","LU2237443895.HKD","LU2357305700.SGD","LU0882574139.USD","IE00BJLML261.HKD","LU2264538146.SGD","IE00B2B36J28.USD","LU1232071149.USD","BK4599","BK4007","SG9999015986.USD","LU0094547139.USD","SG9999015952.SGD","LU0471298777.SGD","SGXZ81514606.USD","SGXZ99366536.SGD","LU0097036916.USD","LU1267930730.SGD","LU0456855351.SGD","LU0256863902.USD","LU1983299246.USD","SGXZ57979304.SGD","01477","LU0122379950.USD","IE00BJJMRZ35.SGD","LU0006306889.USD","LU0198837287.USD"],"gpt_icon":0},{"id":"2529362850","title":"港股异动 | 歌礼制药-B(01672)早盘涨超22% 礼来公布口服降糖药积极结果 ASC30具备更大商业化BD潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362850","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529362850?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:41","pubTimestamp":1745286075,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,歌礼制药-B早盘涨超20%,截至发稿,涨20.65%,报5.96港元,成交额1900.82万港元。消息面上,4月14日,辉瑞因潜在肝损伤终止开发GLP-1小分子受体激动剂Danuglipron。4月17日,礼来宣布口服药Orforglipron的III期ACHIEVE-1研究取得积极顶线结果,在糖化血红蛋白管理、体重控制和安全性方面均与注射剂型相仿,即将申报上市。花卉粗昂证券指出,目前歌礼制药旗下ASC30是唯一一款即可以口服,又可以超长效皮下注射的小分子GLP-1药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LLY","LU1974910355.USD","LU0096364046.USD","LU1061106388.HKD","LU1093756325.SGD","LU2750360641.GBP","LU2552382132.HKD","LU2552382215.SGD","LU0097036916.USD","BK4599","LU0198837287.USD","LU0385154629.USD","LU1868837136.USD","LU0058720904.USD","LU0122379950.USD","LU2237443895.HKD","LU2491049909.HKD","LU2237443622.USD","SGXZ99366536.SGD","BK4533","LU0820561909.HKD","LU2265009873.SGD","LU1712237335.SGD","01477","BK1515","LU1988902786.USD","LU2264538146.SGD","SG9999014914.USD","LU2237443978.SGD","LU1232071149.USD","LU2491050071.SGD","LU0289739699.SGD","LU1551013342.USD","LU0320765059.SGD","LU1989771016.USD","LU1868836757.USD","LU1551013425.SGD","LU2237438978.USD","SG9999018857.SGD","LU0466842654.USD","LU0820561818.USD","LU0256863902.USD","IE00BK4W5L77.USD","IE0009355771.USD","SGXZ51526630.SGD","01672","LU1069344957.HKD","LU2361044865.SGD","LU2089984988.USD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2529236157","title":"安进4月21日成交额为4.94亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529236157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529236157?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:15","pubTimestamp":1745284547,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日,安进成交额为4.94亿美元,成交额较昨日减少58.99%,当日成交量为180.36万股。安进于2025年4月21日跌1.3%,报273.68美元,该股过去5个交易日跌4.3%,年初至今涨5.85%,过去60日跌0.72%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422091557a461bb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422091557a461bb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4585","LU1023059063.AUD","LU1061106388.HKD","SG9999001440.SGD","AMGN","BK4139","LU2242646821.SGD","LU2242652126.USD","BK4581","BK4599","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0122379950.USD","BK4533","LU1571399168.USD","BK4566","LU0289739699.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0002141913.USD","LU1057294990.SGD","LU0109394709.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","LU0320765992.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4588"],"gpt_icon":0},{"id":"2529383675","title":"Altimmune, Inc.盘中异动 急速拉升5.16%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529383675?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:32","pubTimestamp":1745245959,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时32分,Altimmune, Inc.股票出现波动,股价急速上涨5.16%。截至发稿,该股报4.79美元/股,成交量42.2259万股,换手率0.55%,振幅8.13%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.涨幅较大,Aptevo Therapeutics Inc.、Transcode Therapeutics, Inc.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为1074.80%、907.52%、739.63%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为106.34%、58.81%、43.24%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223239aa2c7467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223239aa2c7467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"2529807202","title":"硕迪生物盘中异动 早盘股价大涨5.51%报22.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529807202?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 21:47","pubTimestamp":1745243261,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时47分,硕迪生物股票出现异动,股价急速上涨5.51%。截至发稿,该股报22.96美元/股,成交量8.2101万股,换手率0.14%,振幅8.20%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-1.23亿美元,每股收益-2.33美元,毛利-2.60百万美元,市盈率-9.72倍。机构评级方面,在所有13家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中,整体跌幅为0.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121474194dcef28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042121474194dcef28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4599","GPCR"],"gpt_icon":0},{"id":"2529808331","title":"百亿富豪的生长激素不灵了,355亿“东北药茅”神话破灭?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529808331","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529808331?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 19:22","pubTimestamp":1745234520,"startTime":"0","endTime":"0","summary":" 多元化能否助其再现增长神话? 2008年长春高新还是做房地产业务的,后来收购了金赛药业转型做生长激素,之后业绩和股价实现暴涨。被称为“东北药茅”的长春高新,在二股东金磊与前妻离婚,给了40亿股权“分手费”备受争议之后,4月20日,交出了近20年来首份年度收入同比下滑的成绩单。 年报及一季报公布之后,4月21日,长春高新盘中近乎跌停。市值较2021年巅峰时刻的2118亿元缩水了1763亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-04-21/doc-inetxsmq8547155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","GSK.UK","BK0075","LU2148510915.USD","BK0188","LU1064131003.USD","BK0077","LU1093756168.USD","LU2580892789.USD","LU1064130708.USD","BK4585","BK0046","BK0060","BK0057","LU2580892862.HKD","IE00BZ1G4Q59.USD","300009","LU1093756325.SGD","BK4532","BK4599","BK0042","BK4007","300122","GSK","688276","BK0239","BK0196","BK4588","BK0070","IE00BKVL7J92.USD","LU1829250122.USD","688278","LU0154236417.USD","000661","LU1328615791.USD"],"gpt_icon":1},{"id":"2529765368","title":"响应“国家喊你减肥”号召,诺和诺德与京东健康开启战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2529765368","media":"广州日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529765368?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 17:56","pubTimestamp":1745229391,"startTime":"0","endTime":"0","summary":"生物制药公司诺和诺德与京东健康4月21日正式签署战略合作协议,双方在糖尿病和体重管理领域的合作由此进入新阶段。依托诺和诺德百年深耕慢病领域的专业经验和创新治疗方案,并借助京东健康的全场景医疗服务能力,双方将携手打造肥胖症公众科普专区,助力糖尿病一站式诊疗,全面赋能慢病管理数字化转型升级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504213383080939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0456827905.SGD","LU1093756168.USD","BK1247","BK1583","BK4585","BK1515","BK1571","BK1142","86618","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4532","BK4599","LU0051755006.USD","06618","BK4007","NVO","BK1591","BK1589","BK4588","IE00BKVL7J92.USD","LU0154236417.USD","BK1615"],"gpt_icon":1},{"id":"2529826878","title":"减肥药迈入“吃药时代”?礼来口服神药试验成功,股价飙涨创25年新高!","url":"https://stock-news.laohu8.com/highlight/detail?id=2529826878","media":"金十数据","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529826878?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 16:25","pubTimestamp":1745223912,"startTime":"0","endTime":"0","summary":"在公布一种用于2型糖尿病和肥胖治疗的GLP-1药物口服剂型的三期试验取得积极成果后,礼来股价周四暴涨14%,创下近25年来最大单日涨幅。礼来在声明中指出,这是首个成功完成三期试验的小分子口服GLP-1受体激动剂。周四,Viking股价下跌1.7%,Terns上涨4.5%。同时,试验中未出现肝损伤报告,最高剂量下的不良反应导致8%的受试者中止治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042116252294dca5d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042116252294dca5d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1366192091.USD","LU1061106388.HKD","LU0471298694.HKD","IE00B1BXHZ80.USD","LU0238689110.USD","LU2750360641.GBP","LU0289739699.SGD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU0097036916.USD","GB00BDT5M118.USD","SGXZ99366536.SGD","LU1814569148.SGD","SG9999015978.USD","LU0882574139.USD","LU0820561909.HKD","BK4585","SG9999013999.USD","LU0466842654.USD","SGXZ51526630.SGD","LU2361044865.SGD","SGXZ81514606.USD","LLY","LU1868836914.USD","LU0079474960.USD","LU1712237335.SGD","SG9999015945.SGD","SG9999001176.USD","BK4599","LU2237438978.USD","LU2106854487.HKD","LU2237443465.HKD","SG9999018865.SGD","LU2552382132.HKD","LU1035775433.USD","LU2023250504.SGD","SG9999015952.SGD","LU0708995401.HKD","LU1232071149.USD","LU0385154629.USD","LU2063271972.USD","LU2471134879.HKD","LU2471134952.CNY","LU0256863902.USD","LU0456855351.SGD","LU2324357040.USD","IE00B4R5TH58.HKD","BK4007","LU1267930730.SGD","LU2552382058.USD"],"gpt_icon":1},{"id":"2529286718","title":"减重版司美格鲁肽中国说明书更新,纳入心血管获益结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2529286718","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529286718?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 15:52","pubTimestamp":1745221930,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4157","LU0154236417.USD","NVO","LU1093756168.USD","BK4532","LU1093756325.SGD","BK4599","BK4585","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","MACE","BK4588","BK4183"],"gpt_icon":0},{"id":"2529484485","title":"海外市场 | 美股继续调整,礼来口服减肥药火爆","url":"https://stock-news.laohu8.com/highlight/detail?id=2529484485","media":"Ofweek维科网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529484485?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 13:48","pubTimestamp":1745214520,"startTime":"0","endTime":"0","summary":"美股三大指数延续调整,标普500上周跌1.5%,道指累跌2.7%,纳指跌幅超2.6%,科技股成主要拖累。微软、谷歌等科技巨头普遍下跌;礼来因口服减肥药进展大涨。美联储鹰派表态叠加关税扰动压制市场情绪,资金加速流出美股。纳斯达克金龙指数周跌0.5%,霸王茶姬美股IPO首日暴涨近16%,中概股短期受关税政策与流动性回流双重影响。机构认为,关税政策落地后美股盈利预期或下修,科技股估值压力未充分释放。欧日股市或延续资金流入优势,黄金、原油等避险资产配置需求升温。相关ETF:纳斯达克ETF(513300)标普ETF(159655)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042113484694dc8182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042113484694dc8182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2237443382.USD","LU0882574139.USD","LU1804176565.USD","LU1868836757.USD","SG9999001176.USD","LU1291159041.SGD","LU0708995401.HKD","LU0203201768.USD","BK4599","LU2237438978.USD","LU2265009873.SGD","LU1127390331.HKD","LU0385154629.USD","LU0823416689.USD","SG9999001176.SGD","LU2750360641.GBP","LU2357305700.SGD","BK4534","SG9999015978.USD","BK4007","LU2089984988.USD","GB00BDT5M118.USD","LU1623119135.USD","LU1061106388.HKD","BK4533","LU0471298694.HKD","LU2602419157.SGD","LU1551013342.USD","LU1551013425.SGD","LU0006306889.USD","LU2552382215.SGD","LU1035775433.USD","LU2471134952.CNY","LU0058720904.USD","SGXZ99366536.SGD","LU2324357040.USD","LU0354030511.USD","LU1057294990.SGD","LLY","LU0114720955.EUR","IE00B2B36J28.USD","LU0466842654.USD","LU0096364046.USD","IE0002141913.USD","LU0882574055.USD","BK4585","LU2361044949.HKD","LU0820561909.HKD","LU2361044865.SGD","LU0354030438.USD"],"gpt_icon":0},{"id":"2528786644","title":"数据:UDS、VENOM、ALT 等代币将于下周迎来大额解锁,其中 UDS 解锁价值约 1490 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528786644","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528786644?lang=zh_cn&edition=fundamental","pubTime":"2025-04-20 20:55","pubTimestamp":1745153722,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7411560","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2528107268","title":"诺和诺德、礼来“二王争霸”,国产GLP-1抢夺新适应症,恒瑞医药们不想只做减肥神药","url":"https://stock-news.laohu8.com/highlight/detail?id=2528107268","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528107268?lang=zh_cn&edition=fundamental","pubTime":"2025-04-19 17:46","pubTimestamp":1745055988,"startTime":"0","endTime":"0","summary":"GLP-1(胰高血糖素样肽-1)类药物的适应症不只停留在糖尿病与减重领域,赛道中的玩家们正在加速向其他代谢性疾病及神经系统等更广阔的领域扩围。4月14日,药物临床试验登记与信息公示平台官网显示,信达生物(01801.HK)登记了一项评估玛仕度肽(IBI362)在患有中重度阻塞性睡眠呼吸暂停且肥胖的受试者中有效性和安全性的Ⅲ期临床试验(GLORY-OSA)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504193381946449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1988902786.USD","LLY","LU2360106947.USD","LU1069344957.HKD","LU2552382215.SGD","LU0256863811.USD","LU1023059063.AUD","LU1057294990.SGD","LU1868837300.USD","LU2361045086.USD","SG9999013999.USD","BK4533","LU1989771016.USD","IE00BK4W5M84.HKD","LU0466842654.USD","IE0009355771.USD","LU2471134523.USD","LU0238689110.USD","LU0198837287.USD","BK4585","LU1712237335.SGD","LU0114720955.EUR","LU1868837136.USD","LU1548497426.USD","BK4007","GLP","LU0096364046.USD","LU0203202063.USD","BK4599","LU1917777945.USD","LU0471298777.SGD","SG9999014914.USD","LU2361044865.SGD","LU0943347566.SGD","LU1093756168.USD","SGXZ57979304.SGD","BK4590","IE00BJT1NW94.SGD","LU0079474960.USD","LU0385154629.USD","LU0471298694.HKD","LU0689472784.USD","LU0708995401.HKD","SG9999015986.USD","NVO","LU2264538146.SGD","LU1551013425.SGD","LU2468319806.SGD","LU2237438978.USD","SGXZ99366536.SGD"],"gpt_icon":1},{"id":"2528022915","title":"中银证券安进债券季报解读:利润骤降与份额微变","url":"https://stock-news.laohu8.com/highlight/detail?id=2528022915","media":"新浪基金∞工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528022915?lang=zh_cn&edition=fundamental","pubTime":"2025-04-19 13:43","pubTimestamp":1745041380,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!中银证券安进债券型证券投资基金2025年第1季度报告显示,该基金在一季度面临诸多挑战,其中本期利润大幅下降以及基金份额的细微变动值得投资者关注。本季度,中银证券安进债券A与C的主要财务指标呈现出不同态势。中银证券安进债券A和C的份额变动幅度较小,整体基金份额总额保持相对稳定。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigc/fundfs/2025-04-19/doc-inetspiu0336582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0889565916.HKD","BK4599","LU0122379950.USD","AMGN","BK4585","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1061106388.HKD","LU1571399168.USD","IE00B2B36J28.USD","BK4566","LU1023059063.AUD","BK4588","LU2468319806.SGD","LU0868494617.USD","LU2089984988.USD","SG9999001440.SGD","LU0109394709.USD","BK4581","IE0002141913.USD","BK4533","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0320765992.SGD","LU2112291526.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4534","601696","LU1983299246.USD","LU2242652126.USD","BK0276","IE0009355771.USD","LU0289739699.SGD","BK4139","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2528025157","title":"RootData:ALT 将于一周后解锁价值约 675 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2528025157","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528025157?lang=zh_cn&edition=fundamental","pubTime":"2025-04-19 11:05","pubTimestamp":1745031911,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7410299","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["BK4139","LU1878469433.USD","BK4599","ALT"],"gpt_icon":0},{"id":"2528063324","title":"辉瑞:已计入风险,买入具有卓越估值和收益的股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2528063324","media":"美股研究社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528063324?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 19:39","pubTimestamp":1744976340,"startTime":"0","endTime":"0","summary":"辉瑞管理层并非对股价的熊市视而不见。该公司预计,到2030年,这些药物将成为辉瑞销售额的重大贡献者。总体而言,辉瑞的产品线和战略举措与低迷的市场情绪形成了鲜明对比。辉瑞目前的市值约为1250亿美元,约为其2024年销售额630亿美元的两倍。因此,鉴于其极具吸引力的7倍市盈率和卓越的股息收益率,分析师首次评级为“强力买入”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-18/doc-inetquyn4701364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999011175.SGD","LU0306807586.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1894683348.USD","BK4585","BK4592","BK4007","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","IE00BLSP4452.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1883839398.USD","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999001176.USD","LU0234572021.USD","SG9999001176.SGD","LU0306806265.USD","SG9999002232.USD","LU1894683264.USD","BK4599","IE0002270589.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0170899867.USD","LU0225771236.USD","LU1023059063.AUD","SG9999003800.SGD","BK4533","LU0289739699.SGD","SGXZ57979304.SGD","LU0868494617.USD","BK4588","PFE","LU0456855351.SGD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2528681880","title":"【沃森生物:20价肺炎球菌多糖结合疫苗获临床试验批准】沃森生物公告,公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》,通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品,新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型,用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家,国内尚未有20价肺炎球菌多糖结合疫苗上市销售。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528681880","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528681880?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 19:21","pubTimestamp":1744975312,"startTime":"0","endTime":"0","summary":"沃森生物公告,公司及子公司共同申请的20价肺炎球菌多糖结合疫苗获得国家药品监督管理局签发的《药物临床试验批准通知书》,通知书编号为2025LP01099。该疫苗是在已上市产品13价肺炎球菌多糖结合疫苗基础上开发的迭代升级产品,新增了8型、10A型、11A型、12F型、15B型、22F型和33F型共计7种血清型,用于预防由本品所含20种肺炎球菌血清型引起的感染性疾病。全球已上市20价肺炎球菌多糖结合疫苗的厂家仅有美国辉瑞公司一家,国内尚未有20价肺炎球菌多糖结合疫苗上市销售。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18192149669574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1066051498.USD","LU0225284248.USD","BK0070","LU1057294990.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU0234572021.USD","LU0306806265.USD","SG9999003800.SGD","BK4581","BK0239","LU0225771236.USD","LU1894683348.USD","SG9999002224.SGD","LU0058720904.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0321505439.SGD","SG9999001176.USD","BK0077","LU1883839398.USD","BK4568","BK1141","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4550","LU0289739699.SGD","LU0456855351.SGD","300142","LU0306807586.USD","LU0985481810.HKD","SG9999002232.USD","BK4585","IE00BLSP4239.USD","SG9999013999.USD","BK4592","BK1576","SG9999011175.SGD","SGXZ57979304.SGD","BK4534","LU1066053197.SGD","159646","LU1894683264.USD","BK4007","BK4599","IE00BLSP4452.SGD","BK4533","03347","LU1023059063.AUD"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":121,"code":"91000000","status":"200"}]}}